Please login to the form below

Not currently logged in
Email:
Password:

fertility

This page shows the latest fertility news and features for those working in and with pharma, biotech and healthcare.

Myovant has second phase 3 trial to back its uterine fibroids drug

Myovant has second phase 3 trial to back its uterine fibroids drug

In many cases they cause no symptoms, but around a quarter of women experience pain, abnormal bleeding and other symptoms, and may experience fertility problems.

Latest news

More from news
Approximately 3 fully matching, plus 53 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • Former Novartis exec Richard Smith joins EMD Serono Former Novartis exec Richard Smith joins EMD Serono

    Merck KGaA's US biopharmaceutical business EMD Serono has appointed Richard Smith as senior vice president and head of US fertility and endocrinology. ... Smith will take on responsibility for the two businesses as well as the firm's fertility

  • EMD Serono appoints neurology and immunology SVP EMD Serono appoints neurology and immunology SVP

    Promotes head of US Fertility and Endocrinology Craig Millian. EMD Serono, the US-based biopharma business of Germany's Merck KGaA, has promoted Craig Millian to senior vice president of neurology ... Millian most recently served as senior vice president

  • EMD Serono appoints new US chief medical officer EMD Serono appoints new US chief medical officer

    Leveque's substantial experience in managing integrated global medical affairs teams will be significant to furthering our specialty care focus in neurology, oncology, fertility, and endocrinology and bringing our pipeline forward.”.

  • Grünenthal's Harald Stock joins OvaScience board Grünenthal's Harald Stock joins OvaScience board

    Provides European expertise as fertility company looks to expand beyond US. ... The global fertility market is nearly 10 times larger than the US alone, and growing rapidly,” said Dr Michelle Dipp, CEO of OvaScience.

  • Portland appoints lead for new health communications practice Portland appoints lead for new health communications practice

    She has communicated complex clinical and health economic information about high profile topics, ranging from funding fertility treatment to tackling obesity, to politicians, journalists, health and care professionals, patients and the

More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics